HomeCompareMLPC vs JNJ

MLPC vs JNJ: Dividend Comparison 2026

MLPC yields 31.44% · JNJ yields 3.36%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 MLPC wins by $123.8K in total portfolio value
10 years
MLPC
MLPC
● Live price
31.44%
Share price
$6.36
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$143.8K
Annual income
$19,820.31
Full MLPC calculator →
JNJ
Johnson & Johnson
● Live price
3.36%
Share price
$147.50
Annual div
$4.96
5Y div CAGR
5.8%
Payout ratio
55%
After 10 yrs · $10,000 · DRIP
Portfolio value
$20.0K
Annual income
$827.78
Full JNJ calculator →

Portfolio growth — MLPC vs JNJ

📍 MLPC pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodMLPCJNJ
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, MLPC + JNJ cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
MLPC pays
JNJ pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

MLPC
Annual income on $10K today (after 15% tax)
$2,672.75/yr
After 10yr DRIP, annual income (after tax)
$16,847.26/yr
JNJ
Annual income on $10K today (after 15% tax)
$285.83/yr
After 10yr DRIP, annual income (after tax)
$703.61/yr
At 15% tax rate, MLPC beats the other by $16,143.65/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of MLPC + JNJ for your $10,000?

MLPC: 50%JNJ: 50%
100% JNJ50/50100% MLPC
Portfolio after 10yr
$81.9K
Annual income
$10,324.04/yr
Blended yield
12.60%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on JNJ right now

MLPC
No analyst data
JNJ
Analyst Ratings
20
Buy
17
Hold
3
Sell
Consensus: Buy
Price Target
$228.73
+55.1% upside vs current
Range: $190.00 — $265.00
Altman Z
5.2
Piotroski
4/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

MLPC buys
0
JNJ buys
0
No recent congressional trades found for MLPC or JNJ in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricMLPCJNJ
Forward yield31.44%3.36%
Annual dividend / share$2.00$4.96
Payout ratio50%55%
1-year div growth0%4.2%
5-year div CAGR0%5.8%
Portfolio after 10y$143.8K$20.0K
Annual income after 10y$19,820.31$827.78
Total dividends collected$99.9K$5.6K
Payment frequencyquarterlyquarterly
SectorStockHealthcare

Year-by-year: MLPC vs JNJ ($10,000, DRIP)

YearMLPC PortfolioMLPC Income/yrJNJ PortfolioJNJ Income/yrGap
1← crossover$13,844$3,144.41$10,676$355.77+$3.2KMLPC
2$18,882$4,068.45$11,407$389.39+$7.5KMLPC
3$25,390$5,185.83$12,198$426.53+$13.2KMLPC
4$33,684$6,516.92$13,056$467.62+$20.6KMLPC
5$44,122$8,080.23$13,987$513.12+$30.1KMLPC
6$57,102$9,891.75$14,998$563.56+$42.1KMLPC
7$73,064$11,964.32$16,098$619.52+$57.0KMLPC
8$92,485$14,307.15$17,295$681.69+$75.2KMLPC
9$115,885$16,925.46$18,599$750.82+$97.3KMLPC
10$143,817$19,820.31$20,022$827.78+$123.8KMLPC

MLPC vs JNJ: Complete Analysis 2026

MLPCStock

The investment seeks a return that based on the Performance of the Miller/Howard MLP Fundamental Index (the "index"), which the adviser refer to as the C-Tracks, are unsecured senior debt securities issued by Citigroup Inc. The index is designed to measure the performance of 25 energy master limited partnerships ("MLPs") selected quarterly by a methodology that is based upon certain quantitative fundamental factors of publicly traded MLPs, including distribution growth, estimated capital expenditures and distribution coverage.

Full MLPC Calculator →

JNJHealthcare

Johnson & Johnson is a Dividend King with 62+ years of consecutive dividend increases. A healthcare conglomerate spanning pharmaceuticals, MedTech, and consumer health. JNJ spun off its consumer segment as Kenvue in 2023, focusing on higher-margin pharma and medical devices.

Full JNJ Calculator →
📬

Get this MLPC vs JNJ comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

MLPC vs SCHDMLPC vs JEPIMLPC vs OMLPC vs KOMLPC vs MAINMLPC vs ABBVMLPC vs MRKMLPC vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.